|
 |
|
 |
 |
Market Cap | 186.18M | EPS (ttm) | -2.54 |
P/E | - | EPS this Y | -52.60% |
Forward P/E | 8.56 | EPS next Y | 3666.70% |
PEG | - | EPS past 5Y | 19.90% |
P/S | 0.14 | EPS next 5Y | 0.20% |
P/B | 0.49 | EPS Q/Q | -249.50% |
Dividend | 13.08% | Sales Q/Q | 48.60% |
Insider Own | 2.80% | Inst Own | 91.60% |
Insider Trans | 10.05% | Inst Trans | -0.14% |
Short Float | 3.88% | Earnings | Aug 02/b |
Analyst Recom | 2.00 | Target Price | 9.00 |
Avg Volume | 455.56K | 52W Range | 3.81 - 18.74 |
|
|
|
Glatfelter Corporation, together with its subsidiaries, manufactures and sells engineered materials worldwide. It operates through three segments: Composite Fibers, Airlaid Materials, and Spunlace. The Composite Fibers segment offers food and beverage filtration materials for single-serve coffee and tea products; wallcover base materials for wallpaper manufacturers; metallized products that are used in labels, packaging liners, gift wraps, and other consumer product applications; composite laminates consisting of decorative laminates for use in furniture, household and commercial flooring, and other applications; and specialty engineered products, which are used in electrical energy storage, home, hygiene, and other engineered fiber-based applications. The Airlaid Materials segment supplies absorbent cellulose-based airlaid nonwoven materials that are used to manufacture consumer products, such as feminine hygiene and other hygiene products, specialty wipes, tabletop, adult incontinence, home care, and other consumer and industrial products. The Spunlace segment manufactures spunlace nonwovens for cleaning, high-performance materials, personal care, hygiene, and medical applications. The company was formerly known as P. H. Glatfelter Company. Glatfelter Corporation was founded in 1864 and is headquartered in Charlotte, North Carolina. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Hackett Darrel H. | Director | Sep 07 | Buy | 4.20 | 25,000 | 105,000 | 36,702 | Sep 08 08:55 AM | Fahnemann Thomas | CEO | Sep 06 | Buy | 3.90 | 13,000 | 50,752 | 613,000 | Sep 07 03:19 PM | Fogarty Kevin Michael | Director | Aug 29 | Buy | 4.72 | 25,000 | 118,100 | 50,000 | Aug 30 12:50 PM | HALL J ROBERT | Director | Aug 29 | Buy | 4.66 | 20,000 | 93,120 | 107,573 | Aug 29 03:46 PM | Astley Christopher W. | SVP, Chief Commercial Officer | Aug 01 | Option Exercise | 6.34 | 30,602 | 194,017 | 53,502 | Aug 03 04:58 PM |
|
|
 |
 |
Market Cap | 44.67M | EPS (ttm) | -0.14 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | 123.80% |
PEG | - | EPS past 5Y | - |
P/S | 3.46 | EPS next 5Y | - |
P/B | 10.69 | EPS Q/Q | -363.60% |
Dividend | - | Sales Q/Q | 22.20% |
Insider Own | 34.50% | Inst Own | 37.90% |
Insider Trans | 0.67% | Inst Trans | -46.20% |
Short Float | 1.01% | Earnings | Aug 15/a |
Analyst Recom | 1.00 | Target Price | 3.70 |
Avg Volume | 436.22K | 52W Range | 1.35 - 5.44 |
|
|
|
SpringBig Holdings, Inc. operates a software platform that provides customer loyalty and marketing automation solutions to cannabis retailers and brands in the United States and Canada. The company's platform connects consumers with retailers and brands through SMS marketing, emails, customer feedback system, and loyalty programs to support retailers and brands customer engagement and retention. Its reporting and analytics offerings deliver insights that clients utilize to understand their customer base, purchasing habits, and trends. The company was founded in 2016 and is headquartered in Boca Raton, Florida. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Harris Jeffrey Todd | Chief Executive Officer | Sep 07 | Buy | 1.67 | 39,775 | 66,396 | 69,959 | Sep 08 06:39 AM | Harris Jeffrey Todd | Chief Executive Officer | Sep 06 | Buy | 1.57 | 20,184 | 31,743 | 30,184 | Sep 08 06:39 AM |
|
|
 |
 |
Market Cap | - | EPS (ttm) | -0.21 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | - |
P/S | - | EPS next 5Y | - |
P/B | 1.38 | EPS Q/Q | - |
Dividend | - | Sales Q/Q | 22.20% |
Insider Own | - | Inst Own | - |
Insider Trans | - | Inst Trans | - |
Short Float | - | Earnings | - |
Analyst Recom | - | Target Price | - |
Avg Volume | 39.12K | 52W Range | 0.05 - 1.00 |
|
|
|
SpringBig Holdings, Inc. operates a software platform that provides customer loyalty and marketing automation solutions to cannabis retailers and brands in the United States and Canada. Its platform connects consumers with retailers and brands through SMS marketing, as well as emails, customer feedback system, and loyalty programs to support retailers and brands customer engagement and retention. The company was founded in 2012 and is headquartered in Boca Raton, Florida. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Harris Jeffrey Todd | Chief Executive Officer | Sep 07 | Buy | 1.67 | 39,775 | 66,396 | 69,959 | Sep 08 06:39 AM | Harris Jeffrey Todd | Chief Executive Officer | Sep 06 | Buy | 1.57 | 20,184 | 31,743 | 30,184 | Sep 08 06:39 AM |
|
|
|  |
 |
Market Cap | 255.35M | EPS (ttm) | 1.69 |
P/E | 3.60 | EPS this Y | 155.70% |
Forward P/E | 3.49 | EPS next Y | -31.37% |
PEG | 0.07 | EPS past 5Y | - |
P/S | 0.20 | EPS next 5Y | 48.60% |
P/B | 0.43 | EPS Q/Q | 50.10% |
Dividend | - | Sales Q/Q | 47.30% |
Insider Own | 60.30% | Inst Own | 19.60% |
Insider Trans | -26.25% | Inst Trans | -8.62% |
Short Float | 2.19% | Earnings | Aug 04/b |
Analyst Recom | 2.50 | Target Price | 9.00 |
Avg Volume | 62.87K | 52W Range | 5.68 - 9.35 |
|
|
|
Landsea Homes Corporation designs, constructs, markets, and sells suburban and urban single-family detached and attached homes in California, Arizona, Florida, Texas, and Metro New York. It offers a range of properties, including entry-level and first-time move-up homes. The company was incorporated in 2017 and is headquartered in Newport Beach, California. Landsea Homes Corporation is a subsidiary of Landsea Holdings Corporation. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Hartfield Thomas | Director | Sep 07 | Buy | 5.75 | 800 | 4,600 | 25,662 | Sep 07 08:20 PM | Fadule Mollie | Director | Sep 06 | Buy | 6.22 | 5,000 | 31,100 | 25,000 | Sep 07 08:22 PM | Hartfield Thomas | Director | Sep 06 | Buy | 6.13 | 1,400 | 8,582 | 24,862 | Sep 07 08:20 PM | Ho John | Chief Executive Officer | Aug 12 | Buy | 6.89 | 76 | 524 | 126,017 | Aug 12 06:49 PM | Hartfield Thomas | Director | Aug 11 | Buy | 7.03 | 1,300 | 9,139 | 23,462 | Aug 11 05:16 PM |
|
|
 |
 |
Market Cap | 309.07M | EPS (ttm) | -0.82 |
P/E | - | EPS this Y | 60.50% |
Forward P/E | - | EPS next Y | 46.90% |
PEG | - | EPS past 5Y | 7.20% |
P/S | 22.40 | EPS next 5Y | - |
P/B | 3.53 | EPS Q/Q | -17.90% |
Dividend | - | Sales Q/Q | 14.70% |
Insider Own | 8.50% | Inst Own | 54.90% |
Insider Trans | 166.46% | Inst Trans | 60.65% |
Short Float | 4.20% | Earnings | Aug 11/b |
Analyst Recom | 1.60 | Target Price | 13.29 |
Avg Volume | 2.37M | 52W Range | 2.52 - 8.79 |
|
|
|
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil injection in the United States. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
JEFFS ROGER | Chief Executive Officer | Sep 06 | Buy | 5.57 | 43,820 | 243,990 | 159,827 | Sep 07 08:14 PM | Caligan Partners LP | Director | Sep 06 | Buy | 5.62 | 250,000 | 1,405,000 | 10,643,627 | Sep 07 09:15 AM | Moomaw Scott | SVP, Commercial | Aug 31 | Buy | 4.90 | 2,160 | 10,594 | 9,810 | Sep 01 08:41 PM | Lippe Robert A | Chief Operations Officer | Aug 31 | Buy | 4.90 | 1,918 | 9,407 | 98,026 | Sep 01 08:38 PM | Kaseta Michael | Chief Financial Officer | Aug 31 | Buy | 4.90 | 1,927 | 9,451 | 29,877 | Sep 01 08:38 PM |
|
|
|  |
 |
Market Cap | 282.38M | EPS (ttm) | 0.35 |
P/E | 7.44 | EPS this Y | -67.00% |
Forward P/E | 5.80 | EPS next Y | 11200.00% |
PEG | - | EPS past 5Y | - |
P/S | 0.71 | EPS next 5Y | - |
P/B | - | EPS Q/Q | -95.60% |
Dividend | - | Sales Q/Q | -33.60% |
Insider Own | 0.10% | Inst Own | 31.40% |
Insider Trans | - | Inst Trans | 0.18% |
Short Float | 13.89% | Earnings | Aug 09/a |
Analyst Recom | 2.00 | Target Price | 5.80 |
Avg Volume | 178.02K | 52W Range | 2.33 - 10.40 |
|
|
|
OppFi Inc. operates a financial technology platform that allows banks to offer lending products. Its platform facilitates the OppLoan, an installment loan product; SalaryTap, a payroll deduction secured installment loan product; and OppFi Card, a credit card product. The company is based in Chicago, Illinois. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Vennettilli David | Director | Sep 06 | Buy | 2.75 | 136 | 374 | 13,664 | Sep 07 07:02 PM | Schwartz Todd G. | Chief Executive Officer | Sep 06 | Buy | 2.75 | 4,932 | 13,560 | 329,911 | Sep 07 07:07 PM | SCHWARTZ THEODORE G | Director | Sep 06 | Buy | 2.75 | 4,932 | 13,560 | 329,911 | Sep 07 07:09 PM | Vennettilli David | Director | Sep 02 | Buy | 2.82 | 272 | 768 | 13,528 | Sep 07 07:02 PM | Schwartz Todd G. | Chief Executive Officer | Sep 02 | Buy | 2.82 | 9,864 | 27,833 | 324,979 | Sep 07 07:07 PM |
|
|
 |
 |
Market Cap | 322.29M | EPS (ttm) | -1.35 |
P/E | - | EPS this Y | -170.30% |
Forward P/E | 862.31 | EPS next Y | -58.06% |
PEG | - | EPS past 5Y | - |
P/S | 5.67 | EPS next 5Y | - |
P/B | 0.72 | EPS Q/Q | 104.30% |
Dividend | - | Sales Q/Q | 8.00% |
Insider Own | 0.30% | Inst Own | 54.80% |
Insider Trans | 149.03% | Inst Trans | 3.95% |
Short Float | 1.52% | Earnings | Jul 27/b |
Analyst Recom | 1.00 | Target Price | 13.62 |
Avg Volume | 77.72K | 52W Range | 11.01 - 15.47 |
|
|
|
Blue Foundry Bancorp operates as a bank holding company for Blue Foundry Bank, a savings bank that offers various banking products and services for individuals and businesses. The company offers deposits; and loans, such as one-to-four family residential property, home equity, commercial real estate, multi-family, construction, commercial and industrial, and other consumer loans, as well as home equity lines of credit. As of December 31, 2021, it operated 17 full-service branch offices located in northern New Jersey. The company was formerly known as Boiling Springs Bancorp and changed its name to Blue Foundry Bancorp in July 2019. Blue Foundry Bancorp was founded in 1939 and is based in Rutherford, New Jersey. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Goldstein Robert Thomas | Director | Sep 07 | Buy | 11.08 | 2,500 | 27,698 | 7,500 | Sep 07 06:27 PM | Goldstein Robert Thomas | Director | Sep 06 | Buy | 11.25 | 3,000 | 33,742 | 5,000 | Sep 06 05:59 PM | Kinzler Patrick H. | Director | Sep 02 | Buy | 11.27 | 1,000 | 11,270 | 73,711 | Sep 06 05:42 PM | Kinzler Patrick H. | Director | Sep 02 | Buy | 11.30 | 1,000 | 11,303 | 4,853 | Sep 06 05:42 PM | Kinzler Patrick H. | Director | Aug 25 | Buy | 11.60 | 1,552 | 18,003 | 29,928 | Aug 26 04:26 PM |
|
|
|  |
 |
Market Cap | 1.02B | EPS (ttm) | -1.53 |
P/E | - | EPS this Y | -11.90% |
Forward P/E | - | EPS next Y | 995.70% |
PEG | - | EPS past 5Y | -3.70% |
P/S | 18.55 | EPS next 5Y | 37.00% |
P/B | 6.45 | EPS Q/Q | 2.50% |
Dividend | - | Sales Q/Q | -58.60% |
Insider Own | 0.50% | Inst Own | 34.40% |
Insider Trans | 9.61% | Inst Trans | 17.40% |
Short Float | 15.36% | Earnings | - |
Analyst Recom | 2.00 | Target Price | 15.50 |
Avg Volume | 10.65M | 52W Range | 1.15 - 8.42 |
|
|
|
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library and targeted delivery modalities, which include chimeric antigen receptor T-cell therapy (CAR-T), dimeric antigen receptor T-cell therapy, and antibody drug conjugate, as well as bispecific antibody approach; and Sofusa, a drug delivery technology that deliver biologic directly into the lymphatic system. Its clinical programs in development include anti-CD38 CAR-T therapy for the treatment of multiple myeloma, as well as for amyloidosis and graft versus host disease. The company develops resiniferatoxin, a non-opioid-based TRPV1 agonist neurotoxin for late stage cancer and osteoarthritis knee pain treatment; and ZTlido, a lidocaine delivery system for the treatment of postherpetic neuralgia. It engages in the development of SEMDEXA, an injectable viscous gel formulation, which is Phase III trial for the treatment of sciatica, a pathology of low back pain; SP-103, an investigational non-aqueous lidocaine topical system undergoing clinical development in chronic low back pain condition; and SP-104, a novel low-dose delayed-release naltrexone hydrochloride formulation for the treatment of fibromyalgia. It has collaboration with SmartPharm Therapeutics Inc. to develop gene-encoded antibody vaccine to protect against COVID-19; Celularity, Inc. for initiating Phase I/II clinical study, including up to 94 patients with COVID-19; Mount Sinai Health System to develop COVI-SHIELD, an antibody therapy targeting SARS-CoV-2 infection; and Mayo Clinic for Phase Ib pilot study using sofusa lymphatic drug delivery technology to deliver Ipilimumab in patient with melanoma. The company was founded in 2006 and is based in San Diego, California. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Ji Henry | See Remarks | Sep 07 | Buy | 2.02 | 88,888 | 179,349 | 4,765,805 | Sep 07 06:22 PM | Ji Henry | See Remarks | Sep 06 | Buy | 1.96 | 55,555 | 108,882 | 4,676,917 | Sep 06 05:24 PM | Ji Henry | See Remarks | Aug 26 | Buy | 2.11 | 33,333 | 70,333 | 2,121,362 | Aug 26 05:33 PM | Ji Henry | See Remarks | Aug 25 | Buy | 2.06 | 22,222 | 45,768 | 2,088,029 | Aug 25 05:18 PM | Ji Henry | See Remarks | Jun 14 | Buy | 1.40 | 10,000 | 13,999 | 2,065,807 | Jun 14 05:15 PM |
|
|
 |
 |
Market Cap | 489.07M | EPS (ttm) | -0.63 |
P/E | - | EPS this Y | -42.40% |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | -27.00% |
P/S | 1.52 | EPS next 5Y | - |
P/B | 4.20 | EPS Q/Q | -273.50% |
Dividend | - | Sales Q/Q | 10.70% |
Insider Own | 6.30% | Inst Own | 87.30% |
Insider Trans | 0.36% | Inst Trans | 3.95% |
Short Float | 7.87% | Earnings | Aug 09/a |
Analyst Recom | 2.00 | Target Price | - |
Avg Volume | 58.38K | 52W Range | 38.04 - 92.93 |
|
|
Aug-09-22 05:05PM | Tucows Reports Financial Results for Second Quarter 2022 PR Newswire |
Aug-09-22 05:05PM | Tucows Reports Financial Results for Second Quarter 2022 CNW Group |
Aug-09-22 07:07AM | Ting Fiber, a subsidiary of Tucows, secures up to $200 million USD in financing from Generate Capital PR Newswire |
Aug-09-22 07:07AM | Ting Fiber, a subsidiary of Tucows, secures up to $200 million USD in financing from Generate Capital CNW Group |
Aug-09-22 06:59AM | Edited Transcript of TCX.OQ earnings conference call or presentation 9-Aug-22 10:59am GMT Thomson Reuters StreetEvents |
Jul-26-22 07:48AM | Tucows Announces Timing for Q2 2022 Financial Results News Release and Management Commentary: Tuesday, August 9, 2022 at 5:05 p.m. ET PR Newswire |
Jul-26-22 07:48AM | Tucows Announces Timing for Q2 2022 Financial Results News Release and Management Commentary: Tuesday, August 9, 2022 at 5:05 p.m. ET CNW Group |
May-16-22 07:30AM | Ting Internet to bring next-generation fiber internet to Alexandria, Virginia PR Newswire |
May-09-22 06:22AM | Shareholders in Tucows (NASDAQ:TCX) have lost 37%, as stock drops 13% this past week Simply Wall St. |
May-05-22 05:05PM | Tucows Reports Financial Results for First Quarter 2022 CNW Group |
|
Tucows Inc. provides network access, domain name registration, email, mobile telephony, and other Internet services in Canada, the United States, and Europe. It operates through three segments: Fiber Internet Services, Mobile Services, and Domain Services. The Fiber Internet Services segment provides fixed high-speed Internet access services to individuals and small businesses primarily through the Ting website, and other billing solutions to small internet service providers. The Mobile Services segment offers mobile phones and retail telephony services; and professional services, including implementation, training, consulting, and software development and modification services, as well as operates Mobile Services Enabler platform that provides network access, provisioning, and billing services. The Domain Services segment provides wholesale and retail domain name registration services; portfolio services; and value-added services, such as hosted email, Internet security services, Internet hosting, WHOIS privacy, publishing tools, and other value-added services for end-users under the OpenSRS, eNom, Ascio, and Hover brands. The company was formerly known as Infonautics, Inc. and changed its name to Tucows Inc. in August 2001. Tucows Inc. was incorporated in 1992 and is headquartered in Toronto, Canada. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
NOSS ELLIOT | Chief Executive Officer | Sep 06 | Buy | 45.36 | 1,400 | 63,504 | 2,500 | Sep 07 06:19 PM | NOSS ELLIOT | Chief Executive Officer | Sep 02 | Buy | 46.31 | 1,100 | 50,941 | 1,100 | Sep 07 06:19 PM | Woroch David John | CEO Tucows Domains Services | Aug 23 | Option Exercise | 21.10 | 5,000 | 105,500 | 59,122 | Aug 24 10:20 AM | Singh Davinder | CFO | Aug 12 | Option Exercise | 19.95 | 7,000 | 139,650 | 7,000 | Aug 17 01:48 PM | NOSS ELLIOT | Chief Executive Officer | Dec 10 | Option Exercise | 19.41 | 10,000 | 194,100 | 534,326 | Dec 13 09:27 AM |
|
|
 |
 |
Market Cap | 93.19M | EPS (ttm) | -0.44 |
P/E | - | EPS this Y | -245.30% |
Forward P/E | - | EPS next Y | 9.60% |
PEG | - | EPS past 5Y | - |
P/S | 25.89 | EPS next 5Y | - |
P/B | 2.01 | EPS Q/Q | 37.40% |
Dividend | - | Sales Q/Q | - |
Insider Own | 43.50% | Inst Own | 1.60% |
Insider Trans | 1.42% | Inst Trans | 5.11% |
Short Float | 0.09% | Earnings | Aug 12/b |
Analyst Recom | 2.00 | Target Price | 7.00 |
Avg Volume | 16.79K | 52W Range | 1.76 - 7.05 |
|
|
|
HCW Biologics Inc., a preclinical stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases. The company's lead products include HCW9218, which is an injectable immunotherapeutic for patients with pancreatic, ovarian, breast, prostate, and colorectal cancers, as well as pulmonary fibrosis; and HCW9302 for auto-immune diseases, such as alopecia areata and metabolic diseases. It also develops HCW9201, a cell-based therapy that is in Phase II clinical trials for the treatment of patients with relapsed/refractory acute myeloid leukemia; and HCW9206 for the treatment of acute myeloid leukemia. The company was incorporated in 2018 and is headquartered in Miramar, Florida. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Wong Hing C | Chief Executive Officer | Sep 07 | Buy | 2.58 | 6,000 | 15,480 | 15,296,468 | Sep 07 05:45 PM | Wong Hing C | Chief Executive Officer | Sep 02 | Buy | 2.55 | 4,000 | 10,200 | 15,290,468 | Sep 07 05:45 PM | Byam Rebecca | Chief Financial Officer | Aug 31 | Buy | 2.56 | 10,000 | 25,572 | 282,952 | Sep 01 04:01 PM | Byam Rebecca | Chief Financial Officer | Aug 30 | Buy | 2.55 | 7,200 | 18,341 | 272,952 | Sep 01 04:01 PM | Byam Rebecca | Chief Financial Officer | Aug 29 | Buy | 2.57 | 10,000 | 25,662 | 265,752 | Aug 30 05:20 PM |
|
|
 |
prev12345678910next
|
 |
|